Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Apollo Hospitals Enterprise Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Apollo Hospitals Enterprise Ltd trades at a P/E of 62.38× and P/B of 12.78×.
Valuation
Profitability
Growth
Financial Health
Apollo Hospitals Enterprise Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Apollo Hospitals Enterprise Ltd, switchable between annual and quarterly views, consolidated or standalone.
Apollo Hospitals Enterprise Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,20,994.79 Cr and reported EPS of ₹135.09.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 21,794 | 25,229 |
| Other Income | 32 | 31 | 27 | 45 | 78 | 90 | 106 | 200 | 192 |
| Total Income | 8,276 | 9,649 | 11,274 | 10,605 | 14,741 | 16,703 | 19,166 | 21,994 | 25,420 |
| Cost of Goods Sold (COGS) | 4,033 | 4,661 | 5,499 | 5,684 | 7,573 | 8,574 | 9,806 | 11,310 | 13,076 |
| Gross Profit | 4,211 | 4,957 | 5,748 | 4,876 | 7,089 | 8,038 | 9,254 | 10,484 | 12,153 |
| +Operating Expenses | 3,418 | 3,893 | 4,161 | 3,738 | 4,904 | 5,989 | 6,863 | 7,462 | 8,384 |
| EBITDA | 793 | 1,064 | 1,587 | 1,137 | 2,185 | 2,050 | 2,391 | 3,022 | 3,769 |
| +Non-Operating Expenses | 654 | 723 | 1,351 | 1,083 | 1,273 | 996 | 1,138 | 1,216 | 1,307 |
| Profit Before Tax (PBT) | 171 | 373 | 660 | 221 | 1,578 | 1,144 | 1,363 | 2,006 | 2,616 |
| +Tax Expense | 112 | 173 | 225 | 85 | 477 | 256 | 446 | 534 | 658 |
| Profit After Tax (PAT) | 60 | 200 | 432 | 137 | 1,108 | 845 | 935 | 1,505 | 2,003 |
| Earnings Per Share (EPS) | 8.44 | 16.97 | 32.70 | 10.46 | 73.42 | 56.97 | 62.50 | 100.56 | 135.04 |
| Diluted Shares Outstanding (Nos.) | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| +Additional Disclosures | 12,062 | 13,873 | 16,284 | 16,132 | 21,081 | 24,102 | 27,654 | 31,384 | 36,025 |
| Sales Growth % | — | 16.67 | 16.94 | -6.11 | 38.85 | 13.30 | 14.73 | 14.35 | 15.76 |
| YoY Sales Growth % | — | 16.67 | 16.94 | -6.11 | 38.85 | 13.30 | 14.73 | 14.35 | 15.76 |
| Material Cost % | 18 | 17 | 16 | 15 | 18 | 14 | 13 | 13 | 12 |
| Employee Cost % | 17 | 17 | 16 | 15 | 12 | 13 | 13 | 13 | 12 |
| Other Cost % | 24 | 24 | 21 | 20 | 21 | 23 | 23 | 22 | 21 |
| OPM % | 10 | 11 | 14 | 11 | 15 | 12 | 13 | 14 | 15 |
| Tax % | 65 | 47 | 34 | 38 | 30 | 22 | 33 | 27 | 25 |
| Profit Growth % | — | 236.08 | 115.72 | -68.33 | 710.38 | -23.80 | 10.71 | 60.97 | 33.06 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 434 | 668 | 968 | 564 | 1,584 | 1,434 | 1,704 | 2,264 | 2,893 |
Apollo Hospitals Enterprise segment analysis: revenue and profit mix.
Disclosed business segments at Apollo Hospitals Enterprise with their share of revenue and profit, switchable between consolidated and standalone reporting.
Apollo Hospitals Enterprise discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Apollo Hospitals Enterprise Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Apollo Hospitals Enterprise Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Apollo Hospitals Enterprise Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Substantial market capitalization of ₹112952 Cr indicates strong market presence.
Healthy ROE of 18.4% and ROCE of 16.6% show efficient capital use.
Robust 41.80% surge in quarterly profits demonstrates strong financial health.
Consistent quarterly sales growth of 14.90% reflects sustained market demand.
Impressive 5-year EPS growth of 25.18% indicates strong earnings trajectory.
What can break it.
Elevated P/E ratio of 71.80 suggests potential overvaluation compared to earnings.
Debt-to-equity ratio of 0.96 indicates relatively high leverage, posing financial risk.
Low promoter holding at 28% might raise concerns about corporate governance.
Recent 5-day stock price volatility (-1.51%) highlights market uncertainty and risk.
Low dividend yield of 0.27% may not attract income-focused investors.
What would change my mind.
Trim if P/E re-rates above 81. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 85.65. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 17%. The operating engine is no longer compounding capital efficiently.
Apollo Hospitals Enterprise Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Apollo Hospitals Enterprise Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Apollo Hospitals Enterprise Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Apollo Hospitals Enterprise Ltd — derived from the live tape, not yesterday's close.
Apollo Hospitals Enterprise Ltd last traded at ₹8,411.5 with an intraday range of ₹8,387–₹8,464.5 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹8411.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 8610.00 | +198.50 | +2.36% |
| R3 | 8532.50 | +121.00 | +1.44% |
| R2 | 8498.50 | +87.00 | +1.03% |
| R1 | 8455.00 | +43.50 | +0.52% |
| PIVOT | 8421.00 | 9.50 | 0.11% |
| CURRENT | 8411.50 | — | — |
| S1 | 8222.50 | -189.00 | -2.25% |
| S2 | 8300.00 | -111.50 | -1.33% |
| S3 | 8343.50 | -68.00 | -0.81% |
| S4 | 8377.50 | -34.00 | -0.40% |
APOLLOHOSP is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: 8407.5 ~ 8464.5
Trading Inside opening range
Apollo Hospitals Enterprise Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Apollo Hospitals Enterprise Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Apollo Hospitals Enterprise Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Apollo Hospitals Enterprise Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Apollo Hospitals Enterprise Ltd stood at 72.3% of traded volume, against a 20-day average of 56.7%.
Apollo Hospitals Enterprise announcements: results, concalls, ratings, M&A.
Filings Apollo Hospitals Enterprise sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Apollo Hospitals Enterprise files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 131 documents below.
Resignation
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Resignation of Mr DINESH MADHAVAN as Other of the company w.e.f. May 30, 2026.
General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates
Scheme of Arrangement
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about Transcript
General Updates
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates - Update on Board Meeting
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Analysts/Institutional Investor Meet/Con. Call Updates
Apollo Hospitals Enterprise insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Apollo Hospitals Enterprise as reported to SEBI — buying and selling signals from the people who know the business best.
Apollo Hospitals Enterprise insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| K VISHWESHWAR REDDY | Insider | 04 Apr 2025 | buy | +1.50 L | ₹100.72 Cr | ₹6,714.67 |
| PPN POWER GENERATING CO PVT LTD | Insider | 28 Mar 2025 | buy | +1.3 K | ₹87 L | ₹6,556.14 |
| PPN POWER GENERATING CO PVT LTD | Insider | 24 Mar 2025 | buy | +4.5 K | ₹3.01 Cr | ₹6,688.89 |
| KARTHIK ANAND | Insider | 19 Mar 2025 | buy | +929 | ₹59.6 L | ₹6,415.50 |
| SUNEETA REDDY | Insider | 11 Mar 2025 | buy | +40.0 K | ₹24.54 Cr | ₹6,135.00 |
Apollo Hospitals Enterprise dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Apollo Hospitals Enterprise has declared, sequenced by announce and record date.
Apollo Hospitals Enterprise corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Apollo Hospitals Enterprise Ltd: business, sector, key facts.
What Apollo Hospitals Enterprise Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Apollo Hospitals Enterprise Ltd operates in the Healthcare, listed as NSE: APOLLOHOSP, BSE: 508869.
Apollo Hospitals Enterprise Limited is a leading healthcare provider in India with an international presence. The company's core business revolves around delivering a wide spectrum of healthcare services, encompassing primary, secondary, and tertiary care. This includes a vast array of specialties, ranging from cardiology and oncology to neurosciences and robotic surgery, covering virtually all medical disciplines. Their facilities offer services like transplants, emergency care, and a comprehensive range of diagnostic procedures.
Apollo operates through several distinct segments. The primary segment, Healthcare Services, focuses on its network of hospitals and specialized facilities. Retail Health & Diagnostics encompasses the company's extensive network of pharmacies, clinics, diagnostic centers, and other retail healthcare outlets. The Digital Health & Pharmacy Distribution segment leverages technology through platforms like Apollo 24/7, its mobile health application, and www.apollopharmacy.in, its online pharmacy, to expand access and convenience. Finally, the "Others" segment encompasses diverse activities such as project consultancy, health insurance, medical colleges, and research services.
Beyond its core hospital and clinical services, Apollo's business model is diversified. It includes a substantial retail presence with pharmacies, primary care clinics, and specialized centers for areas such as birthing, dialysis, diabetes management, and dentistry. The company also engages in bio-banking of tissues, indicating a commitment to research and advanced medical technologies. Their educational arm, Medvarsity, provides e-learning opportunities, while their consultancy services extend beyond their direct patient care operations.
In summary, Apollo Hospitals' business strategy focuses on integrated healthcare delivery, combining advanced medical technologies with a broad network of facilities and digital platforms. This integrated approach encompasses a full spectrum of care, from primary healthcare to highly specialized treatments, and utilizes technological advancements to extend its reach and improve accessibility to healthcare services for a wide patient base. Their expansion into diverse related areas such as education, research, and retail demonstrates a comprehensive approach to the healthcare market.
Questions investors ask about Apollo Hospitals Enterprise Ltd (APOLLOHOSP).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP)?
The current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹8,411.5. Today, the stock has declined by ₹16.00 (0.19%), trading in a range of ₹8,387 to ₹8,464.5. The stock opened at ₹8,438.5 with a trading volume of 3,04,242 shares.
02Is Apollo Hospitals Enterprise Ltd stock a good investment for long-term?
Apollo Hospitals Enterprise Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,20,994.79 crores, P/E ratio of 62.38, ROE of 21.50%, and ROCE of 16.60%. The dividend yield stands at 0.24%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Apollo Hospitals Enterprise Ltd stock?
The 52-week high price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹8,624, while the 52-week low is ₹6,696.5. Currently trading at ₹8,411.5, the stock is 89.0% away from its 52-week low and 2.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Apollo Hospitals Enterprise Ltd stock at the current price?
Whether to buy Apollo Hospitals Enterprise Ltd stock at ₹8,411.5 depends on multiple factors. The stock is currently trading with a P/E ratio of 62.38 and P/B ratio of 12.78. Today's performance shows a loss of 0.19%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Apollo Hospitals Enterprise Ltd and when is the next dividend?
Apollo Hospitals Enterprise Ltd offers a dividend yield of 0.24%, which means for every ₹100 invested at the current price of ₹8,411.5, you can expect to receive approximately ₹0.24 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Apollo Hospitals Enterprise Ltd?
Apollo Hospitals Enterprise Ltd's key financial metrics include: P/E Ratio: 62.38, P/B Ratio: 12.78, ROE: 21.50%, ROCE: 16.60%, Dividend Yield: 0.24%, EPS: ₹135.09, Book Value: ₹659.47, and Debt-to-Equity: 85.15. The company's market cap stands at ₹1,20,994.79 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Apollo Hospitals Enterprise Ltd stock performing today in the market?
Apollo Hospitals Enterprise Ltd stock opened at ₹8,438.5 and is currently trading at ₹8,411.5, showing a decline of ₹16.00 (0.19%). The intraday high is ₹8,464.5 and low is ₹8,387. The trading volume stands at 3,04,242 shares, indicating moderate market participation today.
08What is the P/E ratio of Apollo Hospitals Enterprise Ltd and what does it indicate?
Apollo Hospitals Enterprise Ltd has a Price-to-Earnings (P/E) ratio of 62.38, which means investors are willing to pay ₹62.38 for every ₹1 of earnings. With an EPS of ₹135.09, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Apollo Hospitals Enterprise Ltd (APOLLOHOSP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwals Health Care (AGARWALEYE) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- GPT Healthcare (GPTHEALTH) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy